Astellas Pharma · 1 day ago
Real World Data Scientist, Oncology (Associate Director)
Northbrook, IL
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
$141K/yr - $222K/yr
6+ years expAstellas Pharma is a pharmaceutical company focused on developing innovative therapies for patients. They are seeking an experienced real-world data scientist to join their Real-World Data Science team, where the role involves conducting observational studies and collaborating with cross-functional teams to enhance data analytics offerings.
BiotechnologyHealth CareMedical
Responsibilities
Provide best-in-class data science support to Astellas drug development programs & marketed products in relation to RWD
Design of observational studies (primary and/or secondary data)
Execute (program and analyze) observational studies using in-house RWD or oversee vendors or other RWDS staff in executing observational studies
Write, review, or contribute to key study documents to ensure optimal methodological & statistical presentation. These documents include, protocols, analysis plans, tables and figure (TLF) specifications, study reports, publications
Ensure efficient planning, execution and reporting of analyses
Advise as subject matter expert in specific data access partnerships
Represent the company on matters related to RWD analysis at meetings with regulatory authorities, key opinion leaders and similar experts/bodies as needed
Contributes to vendor selection with partner functions
Participate in the creation and upkeep of best practices, tools/macros, and standards related to methods, data and data analysis at Astellas
Collaborate with RWDS and Biostatistics colleagues and cross-functional teams in Development, Medical Affairs and Pharmacovigilance
Mentor and guide junior members of the RWD Analytics team
Qualification
Required
A doctorate or master's degree in statistics, data science, pharmacoepidemiology or a similar discipline
More than 6 years of pharmaceutical industry hands-on experience in design and execution of observational studies and analyzing RWD, including major EHR and claims databases from the US, UK, EU, and/or Japan
Experience in analyzing a diverse set of RWD study types (description, association, prediction, causation), including incidence & prevalence, treatment pattern, healthcare resource utilization, cost, outcomes, and effectiveness
Advanced and broad knowledge of statistical methods, along with understanding of industry practices & guidelines related to the analysis of RWD
Proficiency in SQL, and SAS or R required, with working knowledge of Python beneficial
Well-versed in data visualization, statistical analysis, and machine learning methodologies
Proficiency in non-interventional research design for primary data collection (i.e, prospective) as well as secondary use of data
Committed to seeking innovative methodology to generate data-driven insights
Experience working across geographies with globally distributed teams
Self-starting performer with the demonstrated capacity to operate both independently and collaboratively in a fast-paced, team-oriented setting
Excellent communication and collaboration, and experienced working in cross-functional teams
Benefits
Medical, Dental and Vision Insurance
Generous Paid Time Off options, including Vacation and Sick time, plus national holidays including year-end shut down
401(k) match and annual company contribution
Company paid life insurance
Annual Corporate Bonus and Quarterly Sales Incentive for eligible positions
Long Term Incentive Plan for eligible positions
Company fleet vehicle for eligible positions
Referral bonus program
Company
Astellas Pharma
Astellas Pharma is a global pharmaceutical research & development company.
10001+ employees
H1B Sponsorship
Astellas Pharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (4)
2022 (2)
2021 (3)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
unknownKey Investors
National Institute on Drug Abuse (NIDA)
2020-07-22Grant
2008-10-13IPO
Leadership Team
Amanda Hart
Head, Global Commercial Analytics and Reporting
Recent News
2026-01-07
2025-12-18
Company data provided by crunchbase